Pasteurella multocida infections in baboons (Papio cynocephalus)

The respiratory pathogenPasteurella multocida was isolated from infections of the laryngeal air sacs of two baboons and from abscesses in the neck or femoral area of two other baboons. The infections were associated with surgical procedures involving the cervical area, chronic catheterization, and chair restraint. The organism was also detected among the commensal pharyngeal flora in 2 of 15 clinically healthy, wildborn adult baboons. These findings suggest that the organism is harbored naturally in baboons and that exudative infections can occur secondary to specific procedures.     

Structural analysis of the core oligosaccharide from Pasteurella multocida strain X73

The structure of the core oligosaccharide region of the lipopolysaccharide from the Pasteurella multocida strain X73 was elucidated. The lipopolysaccharide was subjected to a variety of degradative procedures. The structure of the purified oligosaccharide was established by monosaccharide and methylation analyses, NMR spectroscopy and mass spectrometry. The following structure illustrates a similar structure to the recently identified oligosaccharide from another P. multocida strain VP161, but with additional symmetrical substitution of the terminal galactose residues with phosphoethanolamine moieties, where based on the NMR data all sugars were found in pyranose ring forms and Kdo is 3-deoxy-alpha-D-manno-2-oct-2-ulosonic acid, l,D-alpha-Hep is l-glycero-D-manno-heptose, PEtn is phosphoethanolamine and PCho is phosphocholine.     

ThesacB gene cannot be used as a counter-selectable marker inPasteurella multocida

The use of theBacillus subtilis sacB gene as a counter-selectable marker was assessed in serogroup A and B strains ofPasteurella multocida. Expression ofsacB failed to render any of the strains sensitive to sucrose, indicating that thesacB gene can not be used as a positive selection system inP. multocida.     

Structural analysis of the lipopolysaccharide of Pasteurella multocida strain VP161: identification of both Kdo-P and Kdo-Kdo species in the lipopolysaccharide

The structure of the lipopolysaccharide from the Pasteurella multocida strain VP161 was elucidated. The lipopolysaccharide was subjected to a variety of degradative procedures. The structures of the purified products were established by monosaccharide and methylation analyses, NMR spectroscopy and mass spectrometry. The following structures for the lipopolysaccharides were determined on the basis of the combined data from these experiments. [structure: see text]. Based on the NMR data, all sugars were found in pyranose ring forms, and Kdo is 2-keto-3-deoxy-octulosonic acid, L-alpha-D-Hep is L-glycero-D-manno-heptose, PPEtn is pyrophosphoethanolamine and PCho is phosphocholine. Intriguingly, when the O- and fully deacylated LPS was examined, it was evident that there was variability in the arrangement of the Kdo region of the molecule. Glycoforms were found with a Kdo-P moiety, as well as glycoforms elaborating a Kdo-Kdo group. Furthermore the Glc II residue was not attached to Hep I when two Kdo residues were present, but it was attached when the Kdo-P arrangement was elaborated, suggesting a biosynthetic incompatibility due to either steric hindrance or an inappropriate acceptor conformation. This variation in the Kdo region of the LPS was also observed in several other Pasteurella multocida strains investigated including the genome strain Pm70.     

Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin,respectively

Pasteurella multocida is a pathogenic Gram-negative bacterial species that infects a wide variety of animals and humans. A notable morphological feature of many isolates is the extracellular capsule. The ability to remove the capsule by treatment with certain glycosidases has been utilized to discern various capsular types called A, D and F. Based on this preliminary evidence, these microbes have capsules made of glycosaminoglycans, linear polysaccharides composed of repeating disaccharide units containing an amino sugar. Glycosaminoglycans are also abundant components of the vertebrate extracellular matrix. It has been shown previously that the major Type A capsular material was hyaluronan (hyaluronic acid). We report that the Type D polymer is an unmodified heparin (N-acetylheparosan) with a -->4)-beta-D-Glcp-UA-(1-->4)-alpha-D-Glcp-NAc-(1--> repeating unit and the Type F polymer is an unmodified chondroitin with a -->4)-beta-D-Glcp-UA-(1-->3)-beta-D-Galp-NAc-(1--> repeating unit. The monosaccharide compositions, disaccharide profiles, and 1H NMR analyses are consistent with these identifications. The molecular size of the Pasteurella polymers is approximately 100-300 kDa as determined by gel electrophoresis and multi-angle laser light scattering; this size is much greater than the 10-30 kDa size of the analogous polymers isolated from animal tissues. The glycosaminoglycan capsular polymers are relatively non-immunogenic virulence factors that enhance microbial pathogenicity.     

Preparation of L-arabinose isomerase originated from Escherichia coli as a biocatalyst for D-tagatose production

l-Arabinose isomerase for tagatose production from recombinant Escherichia coli was partially purified 15-fold with a specific activity of 70 U mg^–1 protein. The purified enzyme had a major band when it was subjected to SDS/PAGE. With the purified l-arabinose isomerase, 17.7 g tagatose l^–1 was produced from 50 g galactose l^–1 in 168 h which corresponds to a 34% equilibrium.     

Properties of L-arabinose isomerase from Escherichia coli as biocatalyst for tagatose production

L-arabinose isomerase (EC 5.3.1.4) mediates the isomerization of D-galactose into D-tagatose as well as the conversion of L-arabinose into L-ribulose. To investigate the properties of L-arabinose isomerase as a biocatalyst for the conversion of galactose to tagatose, the L-arabinose isomerase of Escherichia coli was characterized. The substrate specificity for L-arabinose was 166-fold higher than that for D-galactose. The optimal pH and temperature for the galactose isomerization reaction were 8.0 and 30 °C, respectively. The enzyme activity was stable for 1 h at temperatures below 35 °C and within a pH range of 8–10. The Michaelis constant, K _m, for galactose was 1480 mM, which is 25-fold higher than that for arabinose. The addition of Fe²⁺ and Mn²⁺ ions enhanced the conversion of galactose to tagatose, whereas the addition of Cu²⁺, Zn²⁺, Hg²⁺, and Fe³⁺ ions inhibited the reaction completely. In the presence of 1 mM Fe²⁺ ions, the K _m for galactose was found to be 300 mM.     

Induction strategies in fed-batch cultures for recombinant protein production in Escherichia coli: Application to rhamnulose 1-phosphate aldolase

Different induction strategies for fed-batch recombinant protein production under the control of the strong T5 promoter in Escherichia coli have been investigated. Since the production of recombinant rhamnulose 1-phosphate aldolase is growth-related, the productivity of the process can be strongly reduced due to the negative effect of protein expression on cell growth. IPTG pulse induction as well as inducer dosage have been applied and their advantages and drawbacks highlighted. Both strategies led to high levels of the recombinant protein, 1000 AU g DCW⁻¹. Inducer concentration and inducer to biomass ratio were identified as the parameters influencing the rate of protein production and final enzymatic activity per gram of biomass. In pulse induction, the maximum enzymatic activity was found at inducer concentration of 70 μM. In continuous induction experiments, inducer concentrations between 4 and 12 μM were identified as the working range in which cell growth and recombinant protein accumulation occurred simultaneously. On the other hand, the amount of IPTG per gram of biomass required was 1.6 μmol IPTG gDCW⁻¹ in pulse induction and between 0.3 and 0.5 μmol IPTG g DCW⁻¹ in continuous induction.     

The control of aldolase in Lemna minor L. in relation to nitrogen deficiency

The loss of activity of aldolase which occurs when Lemna is deprived of nitrogen is shown to be due to the accumulation of a specific inhibitor of aldolase. The inhibitor has been purified 600-fold and has the properties of a low molecular weight protein. The inhibitor is not a proteolytic enzyme and the kinetics of the interaction between aldolase and the inhibitor are reported. The possible physiolgocal significance of the inhibition of aldolase is briefly discussed.     

Cloning, expression, and characterization of a new deoxyribose 5-phosphate aldolase from Yersinia sp. EA015

A new deoC gene encoding deoxyribose 5-phosphate aldolase (DERA) was identified in Yersinia sp. EA015 isolated from soil. The DERA gene had an open reading frame (ORF) of 672 base pairs encoding 223 amino acids to yield a protein of molecular mass 24.8 kDa. The amino acid sequence was 94% identical to that of DERA from Yersinia intermedia ATCC 29909. DERA was over-expressed in Escherichia coli and purified using Ni–NTA affinity chromatography. The specific activity was 137 μmol/min/mg. The Michaelis constant (k_m value) of DERA was 9.1 mM. DERA was optimally active at pH 6.0 and 50 °C. DERA was tolerant to a high concentration (300 mM) of acetaldehyde.     

Construction of genetically modified tobacco (<Emphasis Type="Italic">Nicotiana tabacum</Emphasis> cv. Petit Havana) harboring <Emphasis Type="Italic">ompH(A:3)</Emphasis> from <Emphasis Type="Italic">Pasteurella multocida</Emphasis> (A:3)

Fowl cholera, caused by Pasteurella multocida (A:3), is a fearsome disease leading to a nonproductive influence upon poultry industry. It has been known that outer membrane protein H (OmpH) in the bacterium is a strong candidate to bring on the notorious ailment. Genetically modified (GM) tobacco (Nicotiana tabacum cv. Petit Havana) harboring ompH(A:3) was constructed to develop a plant expression system for the protein, OmpH(A:3). Some 987 bp-long (ORF with the stop codon, TAA) of the ompH(A:3) excluding the nucleotide for signal peptide, was amplified by RT-PCR with the gene specific primers and pGEM-T-ompH(A:3) as template DNA. The PCR-amplified DNA was ligated into BamHI/Sacl-cut pBI121 to obtain a recombinant plasmid, pBI121-ompH(A:3). It was then transformed into Agrobacterium tumefaciens (LBA 4404) by liquid nitrogen method to generate a recombinant clone of Agrobacterium LBA4404/pBI121-ompH(A:3). The Agrobacterium LBA4404/pBI121-ompH(A:3) was inoculated into leaf discs of tobacco (2 day old). The gene-transfected leaves were cultured on Murashige-Skoog basal medium containing kanamycin (50 mg/mL) to generate numerous calli, from which some GM tobacco plants were obtained. Transgenicity of the tobacco plant was confirmed by PCR screening along with the DNA sequencing. Also, its expression in the GM-tobacco was examined qualitatively as well as quantitatively by ELISA/Western blot. These results suggest that the genetically modified tobacco plant can be potentially used as a model system to develop plant-based vaccine against the fowl cholera.     

Rapid and high resolution genotyping of all Escherichia coli serotypes using 10 genomic repeat-containing loci

Our laboratory has previously published two multiple-locus variable-number tandem-repeats analysis (MLVA) methods for rapid genotyping of Escherichia coli (E. coli), which are now in routine use for surveillance and outbreak detection. The first assay developed was specific for E. coli O157:H7; however this assay was not suitable for genotyping other E. coli serotypes. A new generic MLVA-assay was then developed with the capability of genotyping all E. coli serotypes. This generic E. coli MLVA (GECM7) was based on polymorphism in seven variable number of tandem repeats (VNTR) loci. GECM7 worked well with the majority of E. coli serotypes; however we wanted to increase the resolution for this method based in part of comparison with PFGE typing of E. coli O26:H11, where PFGE appeared to display higher resolution. The GECM7 method was improved by adding three new repeat-loci to a total of ten (GECM10), and a considerable increase in resolution was observed (from 296 to 507 genotypes on the same set of strains).     

猪链球菌和猪多杀性巴氏杆菌多重实时荧光PCR方法的建立

【背景】猪链球菌(Streptococcus suis,SS)和猪多杀性巴氏杆菌(Pasteurella multocida,Pm)都是能引起宿主致病的人畜共患病原菌,常出现混合感染,临床诊断上易与猪瘟、猪丹毒等混淆。【目的】快速、有效鉴别猪链球菌病和猪多杀性巴氏杆菌病,建立一种能同时检测2种病原的多重实时荧光定量PCR检测方法。【方法】基于猪链球菌的gdh基因和猪多杀性巴氏杆菌的plpE基因,设计2对特异引物及TaqMan探针,以细菌16S rRNA基因设计通用引物及探针,通过对反应条件优化,建立了一种能同时检测猪链球菌和猪多杀性巴氏杆菌的多重实时荧光定量PCR检测方法。【结果】该方法能够特异性地检测猪链球菌和猪多杀性巴氏杆菌,与细菌分离后的测序结果验证完全一致。此方法对重组质粒标准品的最低检出浓度分别为4.53×10²copies/μL和3.97×10²copies/μL。重复性试验结果显示,该方法的组内和组间变异系数均小于3%。【结论】本实验所建立的方法准确、简便、可靠,能够用于2种病原菌的同时检测,为猪链球菌病和猪多杀性巴氏杆菌病的防治提供了有效的检测工具,具有重要的流行病学意义和临床应用价值。     

Iron(III)hydroxamate transport of Escherichia coli K12: Single amino acid replacements at potential ATP-binding sites inactivate the FhuC protein

Summary The mechanism of iron(III)hydroxamate transport appears to be of the periplasmic binding protein dependent transport (PBT) kind which is energized by ATP hydrolysis. The FhuC protein contains two domains typical of ATP-binding proteins. Lysine in domain I was replaced by glutamine and glutamate, and aspartate in domain II by asparagine and glutamate, resulting in FhuC derivatives which no longer transported ferrichrome and albomycin. FhuC inactivation by the aspartate-glutamate substitution is especially noteworthy since the negative charge thought to be involved in Mg²⁺-ATP binding remains the same and the two amino acid side chains differ in only a CH₂ group. It is concluded that the two domains that represent consensus sequences among all peripheral cytoplasmic membrane proteins of PBT systems are involved in substrate transport.     

The effect of pyridoxal phosphate on the activity of aldolase from Lemna minor L.

Lemna aldolase has been purified by ion-exchange and affinity chromatography. The enzyme is inhibited by pyridoxal phosphate in a manner which suggests that pyridoxal phosphate forms a non-covalent complex with the enzymes which is in equilibrium with the Schiff base covalently modified enzyme. The kinetics of the reversal of inhibition have been used to test the proposition that the fall in aldolase activity observed during periods of nitrogen starvation is due to inhibition by pyridoxal phosphate. It is concluded that the in vivo loss of aldolase activity is not due to pyridoxal phosphate and that the in vitro inhibition of glycolytic enzymes by pyridoxal phosphate is due to the reaction with lysine residues at the active sites which are necessary to bind the strongly acidic sugar phosphates.     

牛巴氏杆菌病多重PCR检测技术的建立与应用

【背景】牛巴氏杆菌病是由血清型(A、B、E)多杀性巴氏杆菌(Pasteurella multocida,Pm)引起的一种严重危害养牛业的重要传染病,病原学聚合酶链反应(polymerase chain reaction,PCR)方法是诊断并防控该病的有效手段。【目的】建立检测血清型(A、B、E)多杀性巴氏杆菌的多重PCR方法,为临床诊断牛巴氏杆菌病和病原分型提供技术支撑。【方法】参考多杀性巴氏杆菌hyaD-hyaC基因、bcbD基因和ecbJ基因特异区域,设计3对特异性引物,以温度梯度PCR法确定适宜退火温度(T_m);采用棋盘试验优化引物浓度并初步建立多重PCR方法;采用重组质粒标准品及阳性菌株菌液确定其敏感性(最小检测量);以8种常见牛感染病原体[溶血性曼氏杆菌(Mannheimia hemolytica)C1655、大肠埃希氏菌(Escherichia coli)C237、产单核细胞李氏杆菌(Listeria monocytogenes)C1597、金黄色葡萄球菌(Staphylococcus aureus)C3053、都柏林沙门氏菌(Salmonella dublin)C79351、副结核分枝杆菌(Mycobacterium paratuberculosis)C1625、牛传染性鼻气管炎病毒(bovine infectious rhinotracheitis virus)CAV1546和牛支原体分离株(Mycoplasma bovis)C65-1]核酸样本确定其特异性;制备3批诊断试剂,对敏感性和特异性样品进行批间和批内试验,确定其重复性;运用建立的方法使用3种不同型号的PCR仪检测敏感性和特异性样品,确定其适用性;通过检测临床样本及人工模拟感染样本评价临床应用效果。【结果】在T_m为55℃时,3对引物浓度分别为0.25、0.30和0.20μmol/L条件下建立多重PCR方法较优,可以同时检测多杀性巴氏杆菌血清A型(821bp)、血清B型(203bp)和血清E型(363bp);该方法敏感性高,对重组质粒标准品pMD-A、pMD-B和pMD-E检测限分别为43.080、3.710和4.350copies/μL,对阳性菌液最低检出限均为10²CFU细菌;其特异性强,仅对血清型(A、B、E)多杀性巴氏杆菌有特异性扩增条带,同时对其他病原体均无扩增条带;该方法重复性良好,批间与批内试验均一致;临床样本及人工模拟感染样本检测结果显示与病原分离鉴定符合率为100%。【结论】成功建立了一种可鉴定不同血清型的牛多杀性巴氏杆菌多重PCR检测方法。     

基于响应面法的高抗原活性禽多杀性巴氏杆菌疫苗培养基的研制与效果评价

【背景】禽多杀性巴氏杆菌(Pasteurella multocida)引发的禽霍乱疫情造成了巨大的危害,而现有培养基存在培养菌密度较低的问题。【目的】研制高抗原活性的禽多杀性巴氏杆菌疫苗培养基。【方法】通过单因素试验、Plackett-Burman试验和响应面分析方法对禽多杀性巴氏杆菌培养基的成分进行调整,并对不同发酵阶段的菌体进行免疫原性测定。最后使用该培养基培养细菌后制备疫苗并通过动物攻毒试验评价其保护效果。【结果】使用研制的培养基培养禽多杀性巴氏杆菌,活菌密度能够在6 h达到约1.84×1010 CFU/mL,增菌效果是对照培养基的2.6倍;免疫原性测定结果显示在生长平台期菌体的抗原活性最高;攻毒试验表明制备的疫苗能够很好地抵抗禽多杀性巴氏杆菌的侵袭。【结论】研制出了高抗原活性的禽多杀性巴氏杆菌疫苗培养基,为疫苗的生产奠定了基础。     

一株兔源A型多杀性巴氏杆菌的分离鉴定和全基因组测序及分析

【背景】多杀性巴氏杆菌可导致猪肺疫、牛出血性败血症和兔出血性败血症等多种疾病,严重威胁多种动物畜牧养殖业的健康发展。【目的】重庆某兔场送检一批病死兔,为研究其病原和治疗方法,对病原进行了微生物分离和全基因组测序分析。【方法】从2022年重庆某兔场送检兔病料中进行细菌分离纯化、生化试验、16S rRNA基因鉴定、荚膜血清型分型、药敏试验和毒力基因检测,同时通过全基因组测序结果进行毒力、耐药基因注释和遗传进化等分子生物学信息分析。【结果】该菌为兔源A:ST74多杀性巴氏杆菌,命名为LXSS001,基因组序列上传到NCBI数据库(登录号为CP119523.1),药敏试验显示该菌对四环素、杆菌肽、复方新诺明和磺胺异恶唑耐药,对头孢噻肟、头孢哌酮和丁胺卡那等药物敏感。全基因组长度为2 480 671 bp,并注释到了58个毒力基因和9类药物的靶向抗药基因。通过联合建树表明其与3480株一致性最高。【结论】本研究完成了一株A型多杀性巴氏杆菌的分离鉴定和全基因组测序,并揭示了其与国内外其他分离株的进化关系,为多杀性巴氏杆菌的后续研究提供了参考依据。     

巴氏杆菌糖酵解酶的黏附作用研究

巴氏杆菌（主要是多杀性巴氏杆菌）可以引起多种动物疫病（巴氏杆菌病）,同时也引起人类感染发病。[目的] 研究巴氏杆菌糖酵解酶对宿主细胞（兔肾细胞）和两种常见分子[纤连蛋白（fibronectin,Fn）和血浆纤维蛋白溶解酶原（plasminogen,Plg）]的黏附作用。[方法] 采用原核表达系统对多杀性巴氏杆菌的糖酵解酶进行表达并纯化及制备多克隆抗体,通过菌体表面蛋白定位检测、黏附与黏附抑制等实验探究巴氏杆菌糖酵解酶的黏附作用。[结果] 菌体表面蛋白检测结果显示除烯醇化酶和丙酮酸激酶外的7个糖酵解酶在多杀性巴氏杆菌表面存在。这7个糖酵解酶均能黏附兔肾细胞,但仅有磷酸葡萄糖异构酶的多克隆抗体能对多杀性巴氏杆菌黏附宿主细胞产生抑制作用。Far Western blotting结果显示9个糖酵解酶均能结合宿主Fn和Plg。招募抑制实验结果显示磷酸葡萄糖异构酶、醛缩酶、磷酸甘油酸变位酶的抗体对多杀性巴氏杆菌结合Fn和Plg都有抑制作用,磷酸果糖激酶、丙糖磷酸异构酶、甘油醛-3-磷酸脱氢酶、磷酸甘油激酶抗体仅对多杀性巴氏杆菌结合Fn或Plg有抑制作用。[结论] 多杀性巴氏杆菌糖酵解酶成员葡萄糖异构酶、磷酸果糖激酶、醛缩酶、丙糖磷酸异构酶、甘油醛-3-磷酸脱氢酶、磷酸甘油激酶、磷酸甘油酸变位酶在多杀性巴氏杆菌黏附宿主细胞或分子过程中发挥作用。该研究的完成将加深巴氏杆菌病分子发病机制的认识,并为巴氏杆菌病的诊断标识筛选、新型疫苗创制和药物靶标筛选等提供基础数据。     

利用CRISPRi挖掘大肠杆菌生物合成D-泛酸的关键基因

【目的】D-泛酸(D-pantothenic acid,DPA)是一种重要的功能化合物,被广泛应用于医疗保健、化妆品、动物食品和饲料等领域,具有良好的市场前景及应用。本研究以实验室保藏的大肠杆菌菌株DPAP10为底盘菌株,利用CRISPR干扰(clustered regularly interspaced palindromic repeats interference,CRISPRi)技术,筛选影响工程菌株DPA生物合成的内源性基因靶点。【方法】构建了p Target和pd Cas9的双质粒CRISPRi系统,可以实现对基因单个或组合表达抑制,摇瓶发酵检测基因抑制对DPA合成的影响;通过实时荧光定量聚合酶链式反应(real-time fluorescence quantitative polymerase chain reaction,RT-q PCR)检测了基因抑制后的转录水平;通过高效液相色谱(high performance liquid chromatography,HPLC)检测了中间代谢物分析代谢通路变化。【结果】成功从126个靶基因中筛选得到5个显著影响DPA合成的关键...